Voices
Nitin Jain
Nitin Jain/X

Nitin Jain: Durable Remission with Imatinib in FIP1L1-PDGFRA Myeloid Neoplasm

Nitin Jain, Professor of Medicine at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Case report of a patient with FIP1L1-PDGFRA fusion with significant extra medullary involvement with cord compression 10+ year remission with single agent imatinib without any chemotherapy indicating exquisite sensitivity of this fusion to imatinib.”

Title: Durable complete remission with imatinib monotherapy in a patient with FIP1L1-PDGFRA rearranged myeloid neoplasm with extramedullary involvement

Authors: Vanthana Bharathi, Wei-Ying Jen, Sangeetha Venugopal, Beenu Thakral, Naval Daver, Kelly Chien, Prithviraj Bose, Lucia Masarova, Naveen Pemmaraju, Guilin Tang, Nitin Jain

Read the Full Article.

Nitin Jain: Durable Remission with Imatinib in FIP1L1-PDGFRA Myeloid Neoplasm

More from Nitin Jain on OncoDaily.

Beenu Thakral cancer Guilin Tang Kelly Chien Lucia Masarova Naval Daver Naveen Pemmaraju Nitin Jain OncoDaily Oncology Prithviraj Bose Sangeetha Venugopal Vanthana Bharathi Wei Ying Jen